Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Biohaven set to take on Allergan, Lilly with new migraine med and 500-plus reps

With a new FDA nod for migraine medicine Nurtec ODT, Biohaven will be going up against serious marketing muscle from Allergan and Eli Lilly. But the company is optimistic about its rollout thanks to an “unbelievable” label and a sales team of more 500 reps, execs said Friday.  Formerly known as rimegepant, Nurtec ODT is a dissolvable oral medication that offers migraine sufferers “early and sustained efficacy,” Biohaven’s neurology […]

Pfizer, Mylan vets tapped for Viatris board, C-suite as merger nears

With the board appointments of former leaders at Pfizer and Mylan, generics megamerger Viatris has already indicated its predecessors would play an outsized leadership role. Now, with nine more Pfizer and Mylan board members moving over––and a Pfizer CFO, to boot––the past is definitively the future at Viatris.  Viatris has fleshed out its 13-member board of […]

Amarin aims for Vascepa boom with doubled sales force nearly in place

Amarin scored an FDA win with blockbuster potential last year when its fish oil-derivative Vascepa received a heart-helping nod on top of statins. Now, with Amarin’s fleshed out sales force nearly in place and prescriptions soaring, the drugmaker is ready to take Vascepa to the next level.  Amarin closed 2019 with a whopping 87% increase […]

AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik

British drugmaker AstraZeneca has spent much of the past few years in asset-sale mode, offloading of a range of its specialty products in return for extra cash to plow into areas such as oncology. Now, AstraZeneca has agreed to divest the rights to one of its GI meds in a move the acquirer is calling a “transformative event” […]

Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round

It took four tries over four years, but Perrigo has finally gotten over the finish line with its generic of Teva’s tricky-to-make ProAir HFA inhaler for chronic obstructive pulmonary disease and asthma.   Perrigo and its manufacturing partner Catalent touted the news jointly today, saying they are releasing a limited supply now of the generic albuterol […]

Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit

Hamstrung by opioid lawsuits and mounting debt, opioid maker Mallinckrodt has spent the past few months taking a hard look at bankruptcy to help cover its debts. Now, with a massive opioid settlement in the works, Mallinckrodt’s specialty generics business will enter court-supervised restructuring to help secure its hefty payments. Mallinckrodt has agreed to a $1.6 […]

Novartis’ hot new eye drug Beovu tied to potential vision loss: experts

Novartis has touted early success for its new eye drug Beovu, but an alert tying the drug to potential vision loss might cause docs to balk when it comes to prescribing the medicine.  The American Society of Retina Specialists (ASRS) issued a note Sunday night to members about 14 cases of retinal vasculitis for Beovu patients, 11 of which were occlusive retinal vasculitis that […]